ENTRADA THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-50.9M | $-55.4M | $4.6M | $2.5M |
| FY2022 | $-93.8M | $-96.7M | $2.9M | $9.9M |
| FY2023 | $139.8M | $134.2M | $5.6M | $13.1M |
| FY2024 | $-41.6M | $-44.7M | $3.2M | $17.9M |
| FY2025 | $-128.5M | $-129.6M | $1.0M | $19.6M |